Juan Aragon
Vorstandsvorsitzender bei VISIONEERING TECHNOLOGIES, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Juan Aragon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VISIONEERING TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.10.2023 | - |
| Vorstandsvorsitzender | 01.10.2023 | - | |
| Optometry Giving Sight | Vorsitzender | - | - |
International Agency for the Prevention of Blindness
 International Agency for the Prevention of Blindness Miscellaneous Commercial ServicesCommercial Services International Agency for the Prevention of Blindness provides promotional activities for the prevention of blindness. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| Vision Aid Overseas | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Juan Aragon
Ehemalige bekannte Positionen von Juan Aragon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SightGlass Vision, Inc.
 SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Direktor/Vorstandsmitglied | - | - |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Corporate Officer/Principal | - | - |
Ausbildung von Juan Aragon
| Instituto Politecnico Nacional | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
| Mexiko | 2 |
Operativ
| Director/Board Member | 6 |
| Chairman | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VISIONEERING TECHNOLOGIES, INC. | Electronic Technology |
| Private Unternehmen | 5 |
|---|---|
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Health Technology |
International Agency for the Prevention of Blindness
International Agency for the Prevention of Blindness Miscellaneous Commercial ServicesCommercial Services International Agency for the Prevention of Blindness provides promotional activities for the prevention of blindness. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Commercial Services |
| Vision Aid Overseas | |
| Optometry Giving Sight | |
SightGlass Vision, Inc.
SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Health Technology |
- Börse
- Insiders
- Juan Aragon
- Erfahrung
